Literature DB >> 13575679

Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods.

G H STOLLERMAN, F S KANTOR, B D GORDON.   

Abstract

The bloods of two apparently healthy human beings, of 25 studied, failed to produce a strong bactericidal test for type-specific antibody to the M protein of group A streptococci under in vitro conditions wherein most human blood leukocytes rapidly phagocytize and destroy virulent organisms in the presence of anti-M antibody and accessory plasma factors. The defect in bactericidal activity of these two individuals is associated with the plasma rather than with the blood leukocytes. Leukocytes suspended in these atypical plasmas showed a characteristic delay in the rate of activation of phagocytosis. Although previously the bloods of laboratory animals (except monkeys) had been reported to be much less active than human blood in this system, occasional exceptions were encountered in rabbits in this study. Two rabbits were found whose bloods were as strongly bactericidal against streptococci, in the presence of type-specific antibody, as the blood of the average "normal" human being. The atypical behavior of some human and rabbit bloods in the bactericidal test may be explained by variations in accessory plasma factors that are as yet unidentified and that influence the rate of phagocytosis of virulent streptococci in vitro in the presence of type-specific antibody.

Entities:  

Keywords:  STREPTOCOCCUS/immunology

Mesh:

Substances:

Year:  1958        PMID: 13575679      PMCID: PMC2136903          DOI: 10.1084/jem.108.4.475

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Type-specific streptococcal antibody.

Authors:  F W DENNY; W D PERRY; L W WANNAMAKER
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

2.  Antimicrobial factors of normal tissues and fluids.

Authors:  R C SKARNES; D W WATSON
Journal:  Bacteriol Rev       Date:  1957-12

3.  Mouse protection and enhancement of phagocytosis by antisera to Streptococcus pyogenes.

Authors:  D G FLECK
Journal:  Br J Exp Pathol       Date:  1956-08

4.  The indirect bactericidal test as a means of identifying antibody to the M antigen of Streptococcus pyogenes.

Authors:  W R MAXTED
Journal:  Br J Exp Pathol       Date:  1956-08

5.  THE OCCURRENCE OF BACTERIOSTATIC PROPERTIES IN THE BLOOD OF PATIENTS AFTER RECOVERY FROM STREPTOCOCCAL PHARYNGITIS.

Authors:  A G Kuttner; T F Lenert
Journal:  J Clin Invest       Date:  1944-03       Impact factor: 14.808

6.  TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES.

Authors:  H F Swift; A T Wilson; R C Lancefield
Journal:  J Exp Med       Date:  1943-08-01       Impact factor: 14.307

7.  Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test.

Authors:  R C LANCEFIELD
Journal:  J Exp Med       Date:  1957-10-01       Impact factor: 14.307

8.  BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : II. COMPARATIVE BACTERIOSTATIC EFFECT OF NORMAL WHOLE BLOOD FROM DIFFERENT ANIMAL SPECIES IN THE PRESENCE OF HUMAN CONVALESCENT SERA.

Authors:  S Rothbard
Journal:  J Exp Med       Date:  1945-08-01       Impact factor: 14.307

9.  Long chain formation by strains of group A streptococci in the presence of homologous antiserum: a type-specific reaction.

Authors:  G H STOLLERMAN; R EKSTEDT
Journal:  J Exp Med       Date:  1957-09-01       Impact factor: 14.307

  9 in total
  21 in total

1.  Alternate complement pathway activation by group A streptococci: role of M-protein.

Authors:  A L Bisno
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

2.  Post-streptococcal glomerulo-nephritis: histopathologic and clinical studies of the acute, subsiding acute and early chronic latent phases.

Authors:  R B JENNINGS; D P EARLE
Journal:  J Clin Invest       Date:  1961-08       Impact factor: 14.808

3.  Recall of type specific antibodies in man by injections of streptococcal cell walls.

Authors:  E V POTTER; G H STOLLERMAN; A C SIEGEL
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

4.  M proteins of group G streptococci isolated from bacteremic human infections.

Authors:  A L Bisno; D E Craven; W R McCabe
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

Review 5.  M proteins of group A streptococci.

Authors:  E N Fox
Journal:  Bacteriol Rev       Date:  1974-03

6.  Secondary and apparent primary antibody responses after group A streptococcal vaccination of 21 children.

Authors:  B F Massell; J G Michael; J Amezcua; M Siner
Journal:  Appl Microbiol       Date:  1968-03

7.  Intraphagocytic degradation of group A streptococci: electron microsopic studies.

Authors:  E M Ayoub; J G White
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

Review 8.  Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.

Authors:  M S Seelig
Journal:  Bacteriol Rev       Date:  1966-06

9.  Protective immunity to the group A Streptococcus may be only strain specific.

Authors:  S A de Malmanche; D R Martin
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

10.  Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF.

Authors:  K H Schmidt; D Gerlach; L Wollweber; W Reichardt; K Mann; J H Ozegowski; B Fleischer
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.